Legal & General Group PLC Summit Therapeutics Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 26,536 shares of SMMT stock, worth $484,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,536

Previous 26,367 0.64%

Holding current value

$484,016

Previous $561,000 1.96%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$17.61 - $30.02 $2,976 - $5,073	169 Added 0.64%	26,536 $550,000
Q2 2025 Aug 12, 2025	BUY	$16.64 - $36.7 $110,855 - $244,495	6,662 Added 33.81%	26,367 $561,000
Q1 2025 May 15, 2025	BUY	$16.65 - $23.76 $160,572 - $229,141	9,644 Added 95.86%	19,705 $380,000
Q4 2024 Feb 13, 2025	BUY	$17.52 - $23.46 $5,991 - $8,023	342 Added 3.52%	10,061 $179,000
Q3 2024 Feb 28, 2025	SELL	$6.89 - $31.93 $2,356 - $10,920	-342 Reduced 3.4%	9,719 $212,000

Q3 2024 Nov 14, 2024	SELL	$6.89 - $31.93 $127,561 - $591,152	-18,514 Reduced 65.58%	9,719 $212,000
Q2 2024 May 29, 2025	SELL	$2.39 - $10.92 $235,861 - $1.08 Million	-98,687 Reduced 83.9%	18,931 $147,000
Q2 2024 Aug 14, 2024	SELL	$2.39 - $10.92 $213,630 - $976,084	-89,385 Reduced 76.0%	28,233 $220,000
Q1 2024 May 29, 2025	BUY	$2.55 - $5.07 $249,678 - $496,418	97,913 Added 496.89%	117,618 $486,000
Q1 2024 May 14, 2024	SELL	$2.55 - $5.07 $3,534 - $7,027	-1,386 Reduced 1.16%	117,618 $486,000
Q4 2023 May 29, 2025	BUY	$1.67 - $2.83 $165,829 - $281,016	99,299 Added 503.93%	119,004 $310,000
Q4 2023 Feb 15, 2024	BUY	$1.67 - $2.83 $1,518 - $2,572	909 Added 0.77%	119,004 $310,000
Q3 2023 Nov 14, 2023	BUY	$1.54 - $2.42 $11,519 - $18,101	7,480 Added 6.76%	118,095 $220,000
Q2 2023 Aug 14, 2023	BUY	$1.32 - $2.81 $146,011 - $310,828	110,615 New	110,615 $277,000
Q2 2022 Aug 22, 2022	SELL	$0.92 - $2.38 $2,548 - $6,592	-2,770 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.83 - $8.27 $1,888 - $3,233	391 Added 16.44%	2,770 $14,000
Q2 2021 Aug 12, 2021	BUY	$5.15 - $8.46 $12,251 - $20,126	2,379 New	2,379 $18,000

Others Institutions Holding SMMT

# of Institutions

263

Shares Held

94.3M

Call Options Held

4.72M

Put Options Held

4.03M

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.67B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Summit Therapeutics Inc. Transaction History